Dynasty Wealth Management LLC Makes New $840,000 Investment in Haleon PLC Sponsored ADR $HLN

Dynasty Wealth Management LLC bought a new position in Haleon PLC Sponsored ADR (NYSE:HLN) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 83,086 shares of the company’s stock, valued at approximately $840,000.

A number of other institutional investors and hedge funds have also modified their holdings of the business. First Eagle Investment Management LLC grew its holdings in shares of Haleon by 9.8% in the third quarter. First Eagle Investment Management LLC now owns 3,056,951 shares of the company’s stock worth $27,421,000 after acquiring an additional 273,044 shares during the period. Cidel Asset Management Inc. bought a new stake in shares of Haleon in the third quarter worth $4,043,000. Optiver Holding B.V. bought a new stake in shares of Haleon in the third quarter worth $45,593,000. JPMorgan Chase & Co. grew its holdings in shares of Haleon by 36.6% in the third quarter. JPMorgan Chase & Co. now owns 11,984,672 shares of the company’s stock worth $107,503,000 after acquiring an additional 3,207,986 shares during the period. Finally, Third View Private Wealth LLC bought a new stake in shares of Haleon in the fourth quarter worth $3,461,000. Institutional investors own 6.67% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Wall Street Zen raised Haleon from a “hold” rating to a “buy” rating in a report on Saturday, March 21st. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Haleon in a report on Thursday, April 30th. Finally, Argus raised Haleon to a “strong-buy” rating in a report on Tuesday, March 17th. Two equities research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy”.

Haleon Price Performance

NYSE HLN opened at $8.72 on Thursday. The company has a market capitalization of $38.61 billion, a PE ratio of 22.35, a price-to-earnings-growth ratio of 1.98 and a beta of 0.13. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.71 and a current ratio of 0.92. The business’s fifty day moving average is $9.45 and its 200 day moving average is $9.94. Haleon PLC Sponsored ADR has a fifty-two week low of $8.65 and a fifty-two week high of $11.28.

Haleon (NYSE:HLN) last released its earnings results on Saturday, February 14th. The company reported $6.32 earnings per share for the quarter. The company had revenue of $3.65 billion for the quarter. Sell-side analysts predict that Haleon PLC Sponsored ADR will post 0.56 earnings per share for the current year.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.